OC-0298 MLC tracking for lung cancer SABR is clinically feasible: results of first-in-human clinical trial

Autor:	O. Ricky, Vincent Caillet, Dasantha Jayamanne, Kathryn Szymura, Nicholas Hardcastle, Thomas Eade, Jeremy T. Booth, Adam Briggs, Paul J. Keall
Rok vydání:	2019
Předmět:	Clinical trial medicine.medical_specialty Oncology business.industry Medicine Radiology Nuclear Medicine and imaging Hematology Radiology First in human business Lung cancer medicine.disease SABR volatility model
Zdroj:	Radiotherapy and Oncology. 133:S150-S151
ISSN:	0167-8140
DOI:	10.1016/s0167-8140(19)30718-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::762c0dbcce63f20dc48ec1060434e173 https://doi.org/10.1016/s0167-8140(19)30718-2 Zobrazit plný text záznamu Full Text from ScienceDirect